Guide 2025, Covering Cellular Processes and Injury, Genetic and Congenital
Disorders, Inflammation and Immune Response, Cardiovascular and
Respiratory Pathophysiology, Neurological and Endocrine Disorders, Renal
and Gastrointestinal Conditions, Musculoskeletal and Hematologic Systems,
Disease Mechanisms and Clinical Manifestations, Evidence-Based Practice,
Practice Questions with Detailed Rationales, Real Clinical Scenarios, Step-
by-Step Explanations, and Proven Strategies to Successfully Pass NURS
6501 on the First Attempt with High Scores
Question 1: Which cellular adaptation is characterized by an increase in cell size due to
enhanced protein synthesis, often in response to increased functional demand?
A. Hyperplasia B. Hypertrophy C. Metaplasia D. Atrophy
CORRECT ANSWER: B. Hypertrophy
RATIONALE: Hypertrophy is an adaptive response where individual cells increase in size due to
elevated protein synthesis and organelle proliferation, typically triggered by increased workload
or hormonal stimulation. Unlike hyperplasia, which involves an increase in cell number,
hypertrophy does not involve cellular division. Metaplasia refers to the reversible replacement
of one mature cell type by another, while atrophy is a decrease in cell size.
Question 2: A patient presents with a genetic disorder characterized by defective chloride
transport across epithelial cells. Which cellular structure is primarily responsible for this
pathophysiological mechanism?
A. Desmosomes B. Gap junctions C. Transmembrane ion channels D. Tight junctions
CORRECT ANSWER: C. Transmembrane ion channels
RATIONALE: The pathophysiology described corresponds to cystic fibrosis, which results from
mutations in the CFTR gene. The CFTR protein functions as a transmembrane chloride channel.
Defective channel regulation leads to thick, viscous secretions in the lungs and pancreas.
Desmosomes provide mechanical adhesion, gap junctions allow intercellular communication,
and tight junctions prevent paracellular transport, but none directly mediate the chloride
transport defect.
Question 3: During the acute inflammatory response, which chemical mediator is primarily
responsible for increasing vascular permeability and causing vasodilation at the site of tissue
injury?
A. Bradykinin B. Histamine C. Interleukin-1 D. Tumor necrosis factor-alpha
,CORRECT ANSWER: B. Histamine
RATIONALE: Histamine is rapidly released from mast cells and basophils upon tissue injury. It
binds to H1 receptors on endothelial cells, causing immediate vasodilation and increased
vascular permeability, leading to edema and redness. Bradykinin contributes to pain and
vasodilation but acts later. Interleukin-1 and TNF-alpha are cytokines that mediate systemic and
prolonged inflammatory responses rather than immediate vascular changes.
Question 4: A nurse practitioner is reviewing laboratory results showing a decreased serum
pH, decreased bicarbonate, and a decreased partial pressure of carbon dioxide. Which acid-
base disorder is most likely present?
A. Metabolic acidosis with respiratory compensation B. Respiratory alkalosis with metabolic
compensation C. Metabolic alkalosis with respiratory compensation D. Respiratory acidosis with
metabolic compensation
CORRECT ANSWER: A. Metabolic acidosis with respiratory compensation
RATIONALE: Metabolic acidosis is characterized by a primary decrease in bicarbonate and a
drop in pH. The respiratory system compensates by increasing ventilation to blow off CO2,
resulting in a decreased PaCO2. Respiratory alkalosis would show elevated pH and low PaCO2.
Metabolic alkalosis presents with elevated pH and high bicarbonate. Respiratory acidosis
features elevated PaCO2 and compensatory increased bicarbonate.
Question 5: Which phase of the cell cycle is primarily targeted by chemotherapeutic agents
that inhibit DNA polymerase activity?
A. G0 phase B. G1 phase C. S phase D. M phase
CORRECT ANSWER: C. S phase
RATIONALE: The S (synthesis) phase is when DNA replication occurs. Chemotherapeutic agents
that inhibit DNA polymerase, such as antimetabolites, specifically target cells during this phase
to prevent DNA synthesis and halt cellular proliferation. G0 is the resting phase, G1 involves cell
growth and preparation for DNA synthesis, and M phase involves mitosis and cytokinesis.
Question 6: A patient develops edema in the lower extremities due to increased capillary
hydrostatic pressure. Which underlying mechanism most directly explains this finding?
A. Decreased plasma oncotic pressure B. Venous obstruction C. Lymphatic channel obstruction
D. Increased capillary permeability
CORRECT ANSWER: B. Venous obstruction
,RATIONALE: Venous obstruction impedes blood return to the heart, causing blood to pool in the
capillaries and increasing capillary hydrostatic pressure. This forces fluid out of the intravascular
space into the interstitial space, resulting in edema. Decreased plasma oncotic pressure (e.g.,
hypoalbuminemia) also causes edema but via reduced inward osmotic pull. Lymphatic
obstruction and increased capillary permeability cause edema through different Starling force
alterations.
Question 7: Which immunoglobulin class is primarily responsible for mediating type I
hypersensitivity reactions through mast cell and basophil degranulation?
A. IgA B. IgG C. IgE D. IgM
CORRECT ANSWER: C. IgE
RATIONALE: IgE binds to Fc receptors on mast cells and basophils. Upon re-exposure to an
allergen, cross-linking of IgE molecules triggers rapid degranulation and release of histamine,
leukotrienes, and other mediators, causing type I hypersensitivity (allergic) reactions. IgA
protects mucosal surfaces, IgG is involved in secondary immune responses and type II/III
hypersensitivity, and IgM is the first antibody produced in primary responses.
Question 8: A patient with chronic kidney disease exhibits metabolic bone disease. Which
hormonal alteration is the primary pathophysiological driver of this condition?
A. Decreased parathyroid hormone secretion B. Increased calcitriol synthesis C.
Hyperphosphatemia-induced secondary hyperparathyroidism D. Decreased fibroblast growth
factor 23
CORRECT ANSWER: C. Hyperphosphatemia-induced secondary hyperparathyroidism
RATIONALE: In chronic kidney disease, impaired phosphate excretion leads to
hyperphosphatemia, which binds calcium and lowers serum ionized calcium. This stimulates
parathyroid hormone (PTH) secretion, causing secondary hyperparathyroidism. Additionally,
reduced renal conversion of vitamin D to calcitriol decreases intestinal calcium absorption,
further exacerbating PTH release and causing renal osteodystrophy. FGF23 is typically elevated,
not decreased, in CKD.
Question 9: Which genetic inheritance pattern is characterized by a 50% chance of affected
offspring when one parent carries a single mutated allele and the trait is expressed in
heterozygotes?
A. Autosomal recessive B. X-linked recessive C. Autosomal dominant D. Mitochondrial
inheritance
CORRECT ANSWER: C. Autosomal dominant
, RATIONALE: Autosomal dominant disorders require only one mutated allele for phenotypic
expression. When one heterozygous parent carries the mutation, each child has a 50% chance
of inheriting the mutated allele. Autosomal recessive requires two mutated alleles. X-linked
recessive primarily affects males and follows different transmission probabilities. Mitochondrial
inheritance is exclusively maternal.
Question 10: In the pathophysiology of heart failure, activation of the renin-angiotensin-
aldosterone system primarily contributes to disease progression through which mechanism?
A. Decreased afterload B. Sodium and water retention C. Enhanced myocardial contractility D.
Vasodilation of coronary arteries
CORRECT ANSWER: B. Sodium and water retention
RATIONALE: Reduced cardiac output in heart failure decreases renal perfusion, triggering renin
release. Angiotensin II causes vasoconstriction, while aldosterone promotes sodium and water
reabsorption in the distal tubules. This increases intravascular volume and preload, initially
maintaining cardiac output but ultimately worsening ventricular dilation, edema, and disease
progression. RAAS activation increases afterload, not decreases it.
Question 11: A patient presents with uncontrolled bleeding and laboratory findings reveal
prolonged prothrombin time and normal partial thromboplastin time. Which coagulation
pathway is most likely impaired?
A. Intrinsic pathway B. Extrinsic pathway C. Common pathway D. Fibrinolytic pathway
CORRECT ANSWER: B. Extrinsic pathway
RATIONALE: The extrinsic pathway is initiated by tissue factor and is primarily measured by
prothrombin time (PT). Prolonged PT with normal aPTT indicates isolated extrinsic pathway
dysfunction, often due to factor VII deficiency or warfarin therapy. The intrinsic pathway is
measured by aPTT. The common pathway affects both PT and aPTT. Fibrinolysis involves clot
breakdown, not initiation.
Question 12: Which cellular process is primarily responsible for the programmed elimination
of damaged or unnecessary cells without inducing an inflammatory response?
A. Necrosis B. Apoptosis C. Autophagy D. Pyroptosis
CORRECT ANSWER: B. Apoptosis
RATIONALE: Apoptosis is a tightly regulated, energy-dependent process of programmed cell
death characterized by cell shrinkage, chromatin condensation, and formation of apoptotic
bodies that are phagocytosed without releasing inflammatory mediators. Necrosis is